Literature DB >> 1730726

Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1.

O Heidenreich1, F Eckstein.   

Abstract

Three ribozymes targeted against different sites of the long terminal repeat RNA (LTR RNA) of human immunodeficiency virus type 1 cleaved a LTR RNA transcript 1,000 x less efficiently than corresponding short synthetic oligoribonucleotide substrates. Varying the stem lengths of the ribozyme resulted in changes of the catalytic efficiency. Almost no cleavage was observed for a ribozyme forming only 10 base pairs instead of 14 with the LTR RNA. Increasing the base pairs to 16 or elongation of the stem formed within the ribozyme revealed only small changes in kcat/Km. The influence of chemical modifications within the ribozyme on the cleavage of the LTR RNA was also examined. 2'-Fluorocytidine substitutions as well as four terminal phosphorothioate internucleotidic linkages influenced the catalytic efficiency of ribozymes only negligibly. However, substitution of uridine by 2'-fluorouridine resulted in a 5-fold decrease of kcat/Km. A ribozyme containing all these modifications revealed only a 7-fold lower catalytic efficiency but a markedly increased stability in cell culture supernatant. These results demonstrate that it is possible to increase the stability of ribozymes toward nucleases without a serious loss in catalytic efficiency.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730726

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Thermodynamics of 2'-ribose substitutions in UUCG tetraloops.

Authors:  D J Williams; J L Boots; K B Hall
Journal:  RNA       Date:  2001-01       Impact factor: 4.942

2.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

3.  Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA.

Authors:  T Kuwabara; M Warashina; T Tanabe; K Tani; S Asano; K Taira
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

4.  Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo.

Authors:  N R Taylor; B E Kaplan; P Swiderski; H Li; J J Rossi
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

5.  Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells.

Authors:  M Homann; M Tabler; S Tzortzakaki; G Sczakiel
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

6.  Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library.

Authors:  A Lieber; M Strauss
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

7.  Can hammerhead ribozymes be efficient tools to inactivate gene function?

Authors:  E Bertrand; R Pictet; T Grange
Journal:  Nucleic Acids Res       Date:  1994-02-11       Impact factor: 16.971

Review 8.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

9.  Reduced beta 2-microglobulin mRNA levels in transgenic mice expressing a designed hammerhead ribozyme.

Authors:  S Larsson; G Hotchkiss; M Andäng; T Nyholm; J Inzunza; I Jansson; L Ahrlund-Richter
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

10.  Translation of 2'-modified mRNA in vitro and in vivo.

Authors:  H Aurup; A Siebert; F Benseler; D Williams; F Eckstein
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.